Wait times and breast cancer survival: a population-based retrospective cohort study using CanIMPACT data
- 15 May 2024
- journal article
- research article
- Published by Springer Nature in Cancer Causes & Control
- Vol. 35 (9) , 1245-1257
Abstract
Purpose The time from breast cancer surgery to chemotherapy has been shown to affect survival outcomes; however, the effect of time from first breast cancer-related healthcare contact to first cancer specialist consultation, or the time from first breast cancer-related healthcare contact to adjuvant chemotherapy on survival has not been well explored. We aimed to determine whether various wait times along the breast cancer treatment pathway (contact-to-consultation, contact-to-chemotherapy, surgery-to-chemotherapy) were associated with overall survival in women within the Canadian province of Ontario. Methods We performed a population-based retrospective cohort study of women diagnosed with stage I–III breast cancer in Ontario between 2007 and 2011 who received surgery and adjuvant chemotherapy. This was the Ontario cohort of a larger, nationwide study (the Canadian Team to improve Community-Based Cancer Care along the Continuum – CanIMPACT). We used Cox-proportional hazards regression to determine the association between the contact-to-consultation, contact-to-chemotherapy, and surgery-to-chemotherapy intervals and overall survival while adjusting for cancer stage, age, comorbidity, neighborhood income, immigration status, surgery type, and method of cancer detection. Results Among 12,782 breast cancer patients, longer surgery-to-chemotherapy intervals (HR 1.13, 95% CI 1.03–1.18 per 30-day increase), but not the contact-to-consultation (HR 0.979, 95% CI 0.95–1.01 per 30-day increase), nor the more comprehensive contact-to-chemotherapy intervals (HR 1.00, 95% CI 0.98–1.02 per 30-day increase) were associated with decreased survival in our adjusted analyses. Conclusion Our findings emphasize the prognostic importance of a shorter surgery-to-chemotherapy interval, whereas the contact-to-consultation and contact-to-chemotherapy intervals have less impact on survival outcomes.Keywords
This publication has 35 references indexed in Scilit:
- Delay in the initiation of adjuvant chemotherapy in patients with breast cancer with mastectomy with or without immediate breast reconstructionBJS Open, 2022
- Survival After Breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic StatusJAMA Surgery, 2021
- Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common CancersJAMA Network Open, 2020
- The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysisBreast Cancer Research and Treatment, 2016
- Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast CancerJAMA Oncology, 2016
- Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic reviewBritish Journal of Cancer, 2015
- Evidence of increasing mortality with longer diagnostic intervals for five common cancers: A cohort study in primary careEuropean Journal of Cancer, 2013
- The Aarhus statement: improving design and reporting of studies on early cancer diagnosisBritish Journal of Cancer, 2012
- Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to Predict Mortality in a General Adult Population Cohort in Ontario, CanadaMedical Care, 2011
- Wait times for breast cancer careBritish Journal of Cancer, 2006